Recent, Positive Efficacy Data for Janssen’s Stelara in Refractory Crohn’s Disease Significantly Boost Patient Share for the IL-12/23 Inhibitor, According to Spherix Global Insights
EXTON, Pa., Sept. 9, 2020 /PRNewswire/ — According to the latest report published as part of Spherix’s RealTime Dynamix™: Inflammatory Bowel Disease US service, gastroenterologists (n=100) continue to report increases in their prescribing of alternative mechanism of action (AMOA) agents,…
Comments Off on Recent, Positive Efficacy Data for Janssen’s Stelara in Refractory Crohn’s Disease Significantly Boost Patient Share for the IL-12/23 Inhibitor, According to Spherix Global Insights